ROLE OF NEUROMODULATION IN MIGRAINE
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
A New Way to Treat Brain Diseases at Home Using Noninvasive Brain Stimulation
The COVID-19 pandemic has highlighted a need for non-invasive, remote approaches to patient care. Dr. Eric Grigsby, CEO and Founder of Neurovations, and Ana Maiques, CEO and Co-founder of Neuroelectrics, […]
NEUROMODULATION: THE SCIENCE
Online November 12-14, 2020 Registration Opening Soon ADVANCING NEUROMODULATION THROUGH COLLABORATION BETWEEN INVASIVE ANDNON-INVASIVE STIMULATION SCIENCE AND TECHNOLOGY Neuromodulation: The Science exists to advance research, dissemination of knowledge, and implementation of […]
Dr. Eric Grigsby Recognized for Visionary Leadership in Pain Management
CEO and Founder of Neurovations Honored as Patient Champion NAPA, Calif., October 16, 2019 (Newswire.com) – Dr. Eric Grigsby was awarded the Visionary Leadership Award at the 6th Annual Business of […]